About Airway Medix S.A.

Company Description

Airway Medix S.A. focuses on research and development work and commercialisation of innovative, disposable devices for the mechanically ventilated patients in the Intensive Care Units (ICU), and for the patients in life-threatening conditions in the anaesthesiology departments.

The family of products developed by Airway Medix is aimed at limiting the growth of a biofilm in patients, reducing the microbial flora in the oral cavity and improving the fitting and tightness of intubation tubes. By reducing biofilm formation and preventing entry of infected material into the lungs, the products protect patients from acquiring Ventilation Associated Pneumonia (VAP).

Ventilation Associated Pneumonia is considered one of the most serious and most costly hospital-acquired infections.

Year founded


Served area



Gen. Zajączka 11/14, 01-510 Warszawa – Poland

Filings & Publications


Report Q1 H1 Q3 FY
Consolidated Report pl
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding



Dec. 1, 2014

Stock exchange(s)

Warsaw Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.